Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Nutritional status and nutritional risk in patients with neuroendocrine tumors

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. eHealth: Disease activity measures are related to the faecal gut microbiota in adult patients with ulcerative colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Colonoscopy adverse events: are we getting the full picture?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pathophysiological-based treatments of complications of cirrhosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Effect of nutritional interventions on discharged older patients: study protocol for a randomized controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Nutrition Impact Symptoms -NIS. Symptomer, der kan påvirke kostindtaget

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  3. Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascites

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Nutritional aspects of chronic diseases

    Publikation: Bog/antologi/afhandling/rapportPh.d.-afhandlingForskning

Vis graf over relationer

BACKGROUND: Malnutrition is frequent among patients with malignancies and associated with impaired function, reduced quality of life and increased mortality. Few data are available in patients with neuroendocrine tumors (NET) on nutritional status, nutritional risk, and nutrition impact symptoms (NIS). We aimed to assess nutritional status (NS) and risk, level of function and associations with NIS in NET patients.

METHODS: In a cross-sectional study of NET patients, we measured body mass index (BMI) and handgrip strength (HGS) as markers of NS and muscle function assessed by HGS. The nutritional risk score (NRS) was determined by NRS-2002. NIS was assessed by the eating symptoms questionnaire (ESQ), and disease-related appetite questionnaire (DRAQ).

RESULTS: We included 186 patients (51% women), median age 66 years. We observed low BMI (<20.5 kg/m2) in 12%, low HGS in 25%, and impaired level of function in 43% of the patients. About 38% were at nutritional risk, more frequent in patients with residual disease (45% versus 29%, p < .05). Both low HGS, impaired level of function and being at nutritional risk were associated with the NIS: Nausea, vomiting, stomach ache and dry mouth (p < .05) whereas poor appetite and early satiety were only associated with being at nutritional risk and having impaired level of function (p < .05, all).

CONCLUSIONS: Almost 40% of NET patients were at nutritional risk; and 25% had impaired HGS associated with specific NIS that preclude food intake. We recommend that NET outpatients are screened with NRS-2002 and that HGS and NIS are determined if NET patients need nutritional therapy.

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Gastroenterology
Vol/bind53
Udgave nummer3
Sider (fra-til)284-292
Antal sider9
ISSN0036-5521
DOI
StatusUdgivet - mar. 2018

ID: 52607228